Primary age‐related EBV‐associated effusion‐based lymphoma successfully treated with rituximab and thoracentesis

EBV‐positive HHV8‐negative EBL is part of the spectrum of EBV‐positive diffuse large B‐cell lymphoma NOS. This entity can be labeled as primary age‐related EBV‐associated EBL and appears to respond well to rituximab and thoracentesis. EBV‐positive HHV8‐negative EBL is part of the spectrum of EBV‐pos...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical case reports 2021-05, Vol.9 (5), p.e03971-n/a
Hauptverfasser:	Kuhlman, Justin J., Alhaj Moustafa, Muhamad, Tun, Alexander J., Menke, David M., Tun, Han W., Jiang, Liuyan
Format:	Artikel
Sprache:	eng
Schlagworte:	aEBV‐EBL Age age‐related EBV‐associated effusion‐based lymphoma Cardiovascular disease Case Report Case reports Cellular biology Chemotherapy EBL EBV‐positive DLBCL‐NOS EBV‐positive HHV8‐negative effusion‐based lymphoma Epstein-Barr virus Heart failure Hepatitis C HIV Human immunodeficiency virus Infections Lymphoma Medical prognosis Morphology Older people Patients Pleural effusion Remission (Medicine) Thoracentesis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	EBV‐positive HHV8‐negative EBL is part of the spectrum of EBV‐positive diffuse large B‐cell lymphoma NOS. This entity can be labeled as primary age‐related EBV‐associated EBL and appears to respond well to rituximab and thoracentesis. EBV‐positive HHV8‐negative EBL is part of the spectrum of EBV‐positive diffuse large B‐cell lymphoma NOS. This entity can be labeled as primary age‐related EBV‐associated EBL and appears to respond well to rituximab and thoracentesis.
ISSN:	2050-0904 2050-0904
DOI:	10.1002/ccr3.3971